Zyn is almost certainly less harmful than traditional dip. It contains no tobacco leaf, produces far lower levels of cancer-causing chemicals, and doesn’t carry the same risk for oral cancer. That said, “safer” doesn’t mean safe. Zyn still delivers nicotine, which is addictive and has real effects on your heart and gums.
The Cancer Risk Gap Is Enormous
The biggest difference between Zyn and dip comes down to a class of chemicals called tobacco-specific nitrosamines, which are among the most potent carcinogens in smokeless tobacco. Traditional snus (a close cousin of American dip) contains up to 1,190 nanograms of NNN, the most dangerous of these chemicals, in a single pouch. The highest amount measured in a nicotine pouch like Zyn was 12.9 nanograms per pouch. That’s roughly 90 times less.
The reason is simple: dip is made from fermented tobacco leaf, which generates these carcinogens during processing and storage. Zyn uses lab-extracted nicotine with no actual tobacco in the pouch. Trace amounts of nitrosamines still show up because the nicotine itself is derived from tobacco plants, but the concentrations are so low they’re closer to what you’d find in nicotine gum than in a can of Copenhagen.
How Nicotine Delivery Compares
Nicotine is the ingredient both products share, and it’s worth understanding how similarly they deliver it. A 6 mg Zyn pouch produces peak blood nicotine levels of about 14.7 ng/mL, reached roughly one hour after you tuck it under your lip. Traditional pouched snus with 10.7 mg of nicotine hits a nearly identical peak of 10.8 ng/mL on a similar timeline. Higher-strength nicotine pouches (8 to 10 mg) can push peak levels to 17 or 18 ng/mL, which is comparable to smoking a cigarette, though the nicotine arrives more gradually.
In practical terms, Zyn and dip are both effective nicotine delivery systems. Neither is a “light” option when it comes to addiction potential. If you’ve never used nicotine, switching from nothing to Zyn still means picking up a habit that’s genuinely hard to quit.
Cardiovascular Effects Are Similar
Nicotine raises your heart rate and blood pressure regardless of how it enters your body. A risk assessment published in 2024 found that even a single nicotine pouch delivers more than 20 times the dose needed to cause a measurable increase in heart rate. This is true for dip as well. The cardiovascular risk from nicotine itself doesn’t change based on the delivery method.
Where dip may carry additional cardiovascular risk is through the thousands of other chemicals in tobacco leaf, some of which promote inflammation in blood vessels. Zyn eliminates that exposure, but the nicotine-driven effects on blood pressure and heart rate remain.
What Zyn Does to Your Gums
Dip is notorious for causing gum recession, white patches (leukoplakia), and oral lesions that can become precancerous. Zyn is gentler on your mouth, but it’s not harmless. Nicotine constricts blood vessels in gum tissue, reducing blood flow and slowing the tissue’s ability to repair itself. Over time, this can contribute to gum recession even without tobacco leaf present.
Consumer complaints reported to the FDA for Zyn most commonly include gum irritation, a burning sensation, and throat irritation. Clinical studies reviewed during the FDA authorization process found that the most frequent side effects were mild oral issues like dry mouth and gum blisters. No deaths or serious adverse events were reported in the evaluated studies.
There’s also a pH factor. Nicotine pouches are deliberately made alkaline, with pH levels ranging from about 7 to 10.4, because alkalinity converts nicotine into a form your body absorbs more easily. That alkaline environment, combined with prolonged contact against your gums and cheeks, creates a persistent chemical exposure that researchers are still working to fully characterize. Flavoring agents like menthol may increase how easily chemicals penetrate your oral tissue and can contribute to low-level inflammation.
What the FDA Says
The FDA authorized 20 Zyn products for sale in January 2025 after reviewing their premarket applications. The agency places nicotine pouches on its “continuum of risk” below cigarettes and other combustible products, stating that for adults who smoke, “switching completely from cigarettes to nicotine pouches may reduce exposure to many harmful chemicals.” The key phrase there is “switching completely.” Using both products, or adding Zyn on top of cigarettes, eliminates the benefit.
Zyn’s manufacturer has also submitted applications asking the FDA to authorize specific reduced-risk marketing claims. As of early 2026, those applications are under scientific review, and no modified risk claims have been approved yet. So while the data strongly suggests Zyn is less harmful than dip, the FDA hasn’t officially signed off on saying so in marketing.
The Bottom Line on Relative Risk
If you’re currently using dip and considering switching to Zyn, the evidence points in your favor. You’d be eliminating exposure to tobacco leaf and the carcinogens that come with it, while keeping a comparable nicotine experience. The reduction in cancer-causing chemicals alone is dramatic.
If you don’t currently use any nicotine product, Zyn isn’t a risk-free option worth picking up. It delivers enough nicotine to create dependence quickly, raises your heart rate and blood pressure with every pouch, and exposes your gum tissue to chronic irritation. The FDA’s own framing is clear: no nicotine product is safe, but some are considerably less dangerous than others. Zyn sits well below dip on that spectrum.